A pharmaceutical company spends hundreds of millions of dollars developing a drug that successfully treats a rare form of cancer. The drug has no other competitors on the market, but the corporation decides to sell it at a very low price in an effort to make it easily available to those who need the life-saving treatment.

According to stakeholder theory, did the corporation fulfill its duty?

• No, because the company should be giving away the drug for free rather than selling it.
• b.)
• No, because the company is failing to maximize the profits it could make through the sale of the drug.
• c.)
• Yes, because the company is advancing an important social interest by making its drug affordable.
• d.)
• Yes, because the officers are following the directives of the board of directors.